Full-Time
Senior Software Engineer
Magnify
11-50 employees
AI-powered post-sales orchestration for growth
Compensation Overview
£60k - £100k/yr
Belfast, UK
Hybrid
 Software Engineering (1) |
|---|
- Bachelors in Computer Science or related field
- 7+ years of experience working as a software engineer building applications in a high growth, startup environment
- Strong proficiency in web application development, including data modelling across relational and non-relational data stores, API development, asynchronous workflow orchestration, and development of web-based UIs (e.g. React)
- Advanced proficiency with Typescript/Javascript, Python, or an equivalent language
- Experience with cloud native environments and Amazon Web Services
- Demonstrated success leading and delivering complex software projects with limited oversight in a distributed environment
- Excellent written and verbal communication skills
- Passionate about delivering for users and collaborating with teammates
- Have a strong bias for action, a track record of moving quickly, and the ability to identify where scrappiness is the right approach versus deeper rigor
- Building out system microservices
- Implementing customer-facing and internal interfaces
- Developing cloud services
- Supporting application integrations
- Working with the data science team to build models and simulations
- Making daily technical decisions
- Contributing code
- Supporting deployment and operations
- Participating in design and quality discussions
- Opportunity to grow with the company and have real impact with upside
Magnify provides an AI-powered platform for post-sales orchestration and customer growth automation, designed for software companies. The platform helps Customer Success, Product, and Revenue teams manage the customer lifecycle at scale by turning data from systems like Salesforce, Gainsight, Pendo, and Snowflake into actionable insights. It uses AI and machine learning to identify what drives churn and expansion, then automatically delivers personalized engagement through emails and in-app messages. This no-code tool lets teams build and automate workflows that connect to existing enterprise systems, reducing manual work and letting teams focus on higher-value tasks. Magnify differentiates itself by creating a distinct category called “Customer Growth Automation,” emphasizing end-to-end lifecycle orchestration across multiple tools rather than building a single-point solution. Its goal is to increase product adoption, cut churn, and grow revenue for enterprise software customers.
Company Size
11-50
Company Stage
Early VC
Total Funding
$12M
Headquarters
Seattle, Washington
Founded
2021
Simplify's Take
What believers are saying
- Manages over $5 billion in revenue for leading software companies, demonstrating strong enterprise adoption.
- CGA Maturity Model framework positions Magnify as category leader in post-sales standardization and scaling.
- Hired Mike Saffitz from Stripe as VP Engineering, strengthening product development and enterprise credibility.
What critics are saying
- Gainsight's AI-native expansions leverage 10,000+ customer base to capture enterprise deals within 6-12 months.
- OpenAI GPT-5 native plugins enable enterprises to build custom automations in-house, commoditizing Magnify's AI.
- SaaS budget cuts force customers to consolidate tools and favor incumbents like Pendo over unproven startups.
What makes Magnify unique
- First platform combining unified data integration, AI churn prediction, and automated multi-channel engagement.
- Agentic AI Assistant proactively executes personalized motions across email, in-app, chat without manual intervention.
- No-code interface enables Customer Success teams to deploy workflows without engineering resources or custom development.
Help us improve and share your feedback! Did you find this helpful?
Your Connections
People at Magnify who can refer or advise you
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Flexible Work Hours
Hybrid Work Options
Remote Work Options
Paid Vacation
Paid Holidays
401(k) Company Match
Wellness Program
Mental Health Support
Phone/Internet Stipend
Home Office Stipend
Conference Attendance Budget
Professional Development Budget
Stock Options
Company Equity
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Parental Leave
Relocation Assistance
Tuition Reimbursement
Professional Certification Support
Mentorship Program
Education allowance
Gym Membership
Commuter Benefits
Meal Benefits
Legal Services
Employee Discounts
Employee Referral Bonus
Bereavement Leave
Vacation/Leave
Growth & Insights and Company News
6 month growth
↓ -3%1 year growth
↑ 3%2 year growth
↑ 16%To address this issue, Magnify, which bills itself as a customer growth optimization platform focused on post-sales optimization, has launched its new AI Assistant, an agent purpose-built to optimize key elements of post-sales revenue generation.
That's why Magnify is excited to launch the Customer Growth Automation (CGA) Maturity Model - a four-phase framework designed to help B2B companies baseline their current approach and identify what's needed to scale retention, renewals, and expansion more efficiently.
The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.The reader should not assume that the information is accurate and complete.
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs
Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Conroy. (Adaptive Biotech Photo)— Seattle biotech company Adaptive Biotechnologies Corp. disclosed in a SEC filing that Kevin Conroy has stepped down from his position as board member.Adaptive announced Conroy’s appointment to its board in May 2019 as it was gearing up for its initial public offering. The company said his departure was voluntary and not a result of any disagreement with its operations, policies or practices.Conroy is the chairman and CEO of Exact Sciences, a publicly traded molecular diagnostics company that focuses on the detection of early-stage cancers. The Madison, Wis.-based firm reported more than $2 billion in revenue last year.The resignation comes after Adaptive board member Leslie Trigg voluntarily resigned in June.— David Meininger confirmed to GeekWire he stepped down from his role as CEO of Link Immunotherapeutics, a Seattle-based company that focuses on developing new immuno-oncology drugs